Albany, NY -- (SBWIRE) -- 08/03/2015 -- Investigation Report on China Tobramycin Market, 2010-2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants.

Browse Complete Report with Toc: http://www.marketresearchreports.biz/analysis/302732

With economic development and the prevalence of computer in work and life, the number of people suffering from eye problems increases by millions each year in China. Therefore, the demand for eye drops to treat infection, inflammation and asthenopia has increased sharply, which boosts the market expansion of relevant drugs. Driven by new drugs, added indications of old drugs and application of drug release technology, ophthalmic drugs have become a category which has attracted much attention.

Tobramycin is a traditional antibiotic whose eye drop and ointment are the most common prescription drugs for the treatment of potential infection or inflammation caused by eye infection. Currently, dozens of enterprises in China are able to produce tobramycin, among which the TOP5 are s.a. Alcon-Couvreur n.v., Sine Pharma, Kangya of Ningxia Pharmaceuticals Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Shanghai Harvest Pharmaceutical Co., Ltd who together dominate the market by taking up a share of over 90%.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/302732

Tobramycin has begun to stabilize in recent years despite a rapid development ever since its entry into China. According to the statistics of 22 sample hospitals in key cities, the sales value of tobramycin was CNY 20.12 million in 2014 with a year-on-year growth of 3.93% and CAGR during the period of 2010-2014 reached 1.22%. As the incidence of eye disease keeps going up, tobramycin still enjoys a vast market in China. Although s.a. Alcon-Couvreur n.v. took up the largest market share of about 72% for sales value in 2014, local enterprises reported a fast growth in market share due to their increasing emphasis on ophthalmic drugs, which brought about a decline of 4.64% to s.a. Alcon-Couvreur n.v. in 2014. As local enterprises continue to progress, their market share is expected to keep growing in the next few years despite a dominance of imported drug in tobramycin market.

Browse More Reports Of Therapeutic Area Reports: http://www.marketresearchreports.biz/category/37

Readers can get at least the following information from this report:
market size of tobramycin in China
competitive landscape of tobramycin in Chinese market
price of tobramycin made by different enterprises in China
market outlook of tobramycin in China
The author suggests the following groups of people purchase this report:
manufacturers of ophthalmic drugs
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: 518-621-2074
Website: http://www.marketresearchreports.biz/